The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Role of the SPA17-AXL Pathway in Melanoma Progression and the Antitumor Potential of SPA17-Targeted Vaccination

  • By

  • Lan Zhang

  • Mengshu You

  • Bin Yan

  • Jian Zhang

  • Yi Yao

  • Qingyan Zhang

  • Zuozhong Xie

  • Shixiang Wang

  • Qian Gao

  • September 9, 2026

Share

Original Source(s)

The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy

  • by Lan Zhang, Mengshu You, Bin Yan, Jian Zhang, Yi Yao, Qingyan Zhang, Zuozhong Xie, Shixiang Wang, Qian Gao

  • September 9, 2026

Related Content

Editorial: Tumor microenvironment and personalized therapy of gastrointestinal cancer Ⅱ

CAR T Before Surgery Improves Glioblastoma Control in Mice

Study finds that tumor resection creates a more immunosuppressive environment and that earlier CAR T cell treatment prolongs survival

  • September 7, 2026

  • 3 min
Case Report: Possible spatially-distinct de novo invasive cervical carcinoma in the setting of isolated persistent HPV16 after ALA-PDT-mediated histological clearance of CIN3